FDA To Study Drug Safety For Pregnant Women, Fetuses

Law360, New York (January 6, 2010, 3:59 PM EST) -- The U.S. Food and Drug Administration has launched a new program to fund research on the effects of women's prescription drug use during pregnancy on both mothers and fetuses, the agency said.

The agency announced the Medication Exposure in Pregnancy Risk Evaluation Program on Monday, explaining that the program will be a collaborative effort between the FDA and researchers in the private sector.

Research shows that approximately two-thirds of women who deliver a baby have taken at least one prescription medication while pregnant, yet there have...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.